Spiration Inc. Obtains $26,900,000 Series E Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=666baf2c-6f6c-4ac6-92ce-cee83f0eeb2e&Preview=1 -
Date
1/6/2004 -
Company Name
Spiration Inc. -
Mailing Address
6675 185th Avenue N.E. Redmond, WA 98052 -
Company Description
Spiration Inc. designs, manufactures and markets innovative Medical Devices & Instruments for the treatment of lung disease, including lung cancer and chronic obstructive pulmonary disease (COPD), which together claim nearly 275,000 lives in the United States each year, according to the American Lung Association and the American Cancer Society. -
Website
http://www.spiration.com -
Transaction Type
Venture Equity -
Transaction Amount
$26,900,000 -
Transaction Round
Series E -
Proceeds Purposes
The current round of financing will be used to prepare for the launch of the VALR(TM) Surgical System and will fund clinical trials for the company’s second product, the Intra-Bronchial Valve (IBV(TM)). -
M&A Terms
-
Venture Investor
Investor Growth Capital -
Venture Investor
New Enterprise Associates -
Venture Investor
Guidant Corporation -
Venture Investor
Three Arch Partners -
Venture Investor
Versant Ventures -
Venture Investor
New Leaf Venture Partners -
Venture Investor
InterWest Partners
